Delivery Order SPE2DB20D3103-SPE2DB25FL7Q5
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a prescription medication. The $2,752.61 firm fixed price delivery order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical commodities,...
This federal contract award, valued at $2,543.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of 4564896600 - ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a completion date of June 14, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,132.71 Firm Fixed Price Delivery Order covers the supply of Zonisade 100 mg/5 ml oral suspension in 150 ml bottles, with a performance period through May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,235.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4564767779 ZONISAMIDE 100 MG CAPSULE 100S, a generic pharmaceutical product. The award has an ultimate completion date of June 3, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside award. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,726.40 firm fixed-price delivery order covers the supply of the drug product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,912.89 firm-fixed-price delivery order contract, awarded on March 8, 2024, covers the supply of the pharmaceutical product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 11, 2024 and is not designated with a set-aside requirement, indicating open competition....
This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,145.72 firm fixed-price delivery order is for the supply of the medication ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, with a period of performance through November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...